; Juniper Pharmaceuticals | Board of Directors

Board of Directors

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeCompensation CommitteeNominating & Corporate Governance Committee
Cristina Csimma, PharmD, MHP 
Cristina Csimma, PharmD, MHP
Director


A director of the Company since September 2010, Dr. Csimma is also Executive Chair of Board of Directors for Exonics Therapeutics (rare diseases) and Neuralstem, Inc. (nervous system diseases). She has been engaged in strategic advisory roles with the biopharmaceutical and venture capital industries, as well as government and patient organizations.

Dr. Csimma was a director at Vtesse Inc. (rare diseases), and was a President and the founding Chief Executive Officer of Cydan Developm... 

  Committee Member Committee Member
James A. Geraghty 
James A. Geraghty
Chairman of the Board


Jim Geraghty has been a director of the Company since May 2015 and was elected Chairman of the Board in July 2015. He is an industry leader with 30 years of strategic and leadership experience, including more than 20 years as a senior member of executive teams at biotechnology companies developing and commercializing innovative therapies. Mr. Geraghty serves as Chairman of the Board of Idera Pharmaceuticals. He also serves a director on the Boards of Pieris Pharmaceuticlas, Inc., Fulcrum Ther... 

Committee Member   Chairperson
Jennifer Good 
Jennifer Good
Director


Ms. Good joined the Board of Directors in September 2017. She is the co-founder, president and chief executive officer at Trevi Therapeutics, a late-stage clinical development company. She also serves on the Board of Directors for Trevi Therapeutics and the Friedreich’s Ataxia Research Association (FARA). Prior to founding Trevi, she served as president and chief executive officer and as chief financial officer at Penwest Pharmaceuticals, where she successfully led the transition of Penwest Phar... 
Committee Member Committee Member  
Mary Ann Gray, Ph.D. Financial Expert
Mary Ann Gray, Ph.D.
Director


Dr. Mary Ann Gray was appointed to Juniper’s board of directors in March 2016 and serves as audit committee Chair.

Dr. Gray has more than 20 years of experience in the biotechnology and biopharmaceutical industry. She is currently President of Gray Strategic Advisors, LLC, a biotechnology strategic planning and advisory firm.

Previously, a Senior Analyst and Portfolio Manager for the Federated Kaufmann Fund, Dr. Gray also covered large- and small-cap biotechnology compa... 

Chairperson   
Ann Merrifield 
Ann Merrifield
Director


Ms. Merrifield, a director of the Company since July 2015, was formerly the President and Chief Executive Officer of PathoGenetix, Inc., a genomics company. Prior to that, she spent 18 years at the Genzyme Corporation where, among other roles, she served as Senior Vice President, Business Excellence, President of Genzyme Biosurgery, and President of Genzyme Genetics. She was previously a partner at Bain and Company and an investment officer at Aetna Life & Casualty.

Ms. Merrifield e... 

  Chairperson Committee Member
Nikin Patel, PhD, MRPharmS 
Nikin Patel, PhD, MRPharmS
Chief Operating Officer


Dr. Nikin Patel co-founded and is the former Chief Executive Officer of Molecular Profiles (now known as Juniper Pharma Services). He joined our board of directors in September 2013 when Molecular Profiles was acquired by Juniper Pharmaceuticals (formerly Columbia Laboratories). Dr. Patel has over 20 years’ management and technical experience centered on pharmaceutical analysis and formulation development. His leadership was recognized externally through the U.K.’s most prestigious industry a... 

   
Alicia Secor, MBA 
Alicia Secor, MBA
President and Chief Executive Officer


Alicia Secor joined Juniper Pharmaceuticals as Chief Executive Officer in August 2016 and serves as a Director of the Company. Ms. Secor brings more than 25 years’ of leadership experience as a life sciences executive, with a track record in leading businesses and advancing products from clinical development through regulatory approval, commercialization, and global expansion across several therapeutic areas.

Ms. Secor joined Juniper from Zafgen, Inc., where she was Chief Commercial... 

   

Advisor to the Board

 
Martyn Davies, BSc, PhD, FRPharmS, CChem, FRSC 
Martyn Davies, BSc, PhD, FRPharmS, CChem, FRSC
Advisor to the Board


Dr. Martyn Davies has over 30 years’ experience in the pharmaceutical, biopharmaceutical and drug delivery fields. He serves as an Advisor to its Board of Directors.

Dr. Davies is a Professor and former Head of School at the University of Nottingham School of Pharmacy, and cofounded the Laboratory of Biophysics and Surface Analysis (LBSA), the leading Research Division of the School. The LBSA has an international reputati...